Source: Eur Respir J, 56 (3) 1902292; 10.1183/13993003.02292-2019



Rating:

Share or cite this content

Citations should be made in the following way:
Arno Vanstapel, Stijn E. Verleden, Birgit Weynand, Eric Verbeken, Laurens De Sadeleer, Bart M. Vanaudenaerde, Geert M. Verleden, Robin Vos. Late-onset “acute fibrinous and organising pneumonia” impairs long-term lung allograft function and survival. Eur Respir J, 56 (3) 1902292; 10.1183/13993003.02292-2019

Member's Comments

No comment yet.

Related content which might interest you: Acute exacerbation of idiopathic pulmonary fibrosis as the initial presentation of the disease Source: Eur Respir Rev 2009; 18: 129-132 Year: 2009 Predictors of survival in idiopathic interstitial pneumonia Source: Annual Congress 2007 - Considerations in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases Year: 2007 Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study Source: Eur Respir J 2012; 40: 101-109 Year: 2012 Survival after respiratory hospitalization in patients with idiopathic chronic fibrosing interstitial pneumonia Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias? Year: 2018 Acute exacerbation of interstitial lung diseases as a cause of respiratory failure. Our 3-years experience Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 Survival of patients with biopsy-proven usual interstitial pneumonia and nonspecific interstitial pneumonia Source: Eur Respir J 2002; 19: 1114-1118 Year: 2002 High short-term mortality following lung biopsy for usual interstitial pneumonia Source: Eur Respir J 2001; 17: 175-179 Year: 2001 Evaluation of lung mechanics and the progression of disease in acute allograft rejection after lung transplantation Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation Year: 2010 Post-transplant bronchiolitis obliterans Source: Eur Respir J 2003 Dec 01;22(6):1007-1018 Year: 2003 Potential causes of acute deterioration in patients with interstitial lung disease Source: Annual Congress 2010 - Different patterns of interstitial lung disease Year: 2010 Recombinant thrombomodulin improves survival in acute exacerbation of idiopathic pulmonary fibrosis Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Clinical course and outcomes of acute exacerbation of fibrosing interstitial lung disease Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation Source: Eur Respir J 2011; 37: 164-172 Year: 2011 Clinical features and outcome of patients with acute exacerbation of interstitial pneumonia associated with collagen vascular disease Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010 Diffuse parenchymal lung diseases presenting with acute hypoxemic failure  Source: International Congress 2017 – Pulmonary emergencies year in review Year: 2017 Eight-year pulmonary function outcome after severe neonatal respiratory failure Source: Eur Respir J 2005; 26: Suppl. 49, 668s Year: 2005 Better survival outcomes after bilateral lung transplantation compared to single lung transplantation in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Chronic lung allograft rejection: prevalence, pathology, risk factors and pathophysiology Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=1 Year: 2004 Difference of immune response in patients with severe acute pneumonia and lung abscesses Source: Eur Respir J 2004; 24: Suppl. 48, 189s Year: 2004